FilingSEC EDGAR6-K
NovaBridge Biosciences Appoints Martin Dewhurst as Independent Director
· SEC accepted
StageCorporate Governance
Filing content
NovaBridge Biosciences has appointed healthcare veteran Martin Dewhurst as an independent director and member of the Audit and Compensation Committees, effective immediately.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…